Hearing problems in humans and mouse models with rare copy number variants associated with schizophrenia: a scoping review protocol
Authors:
- Stephen MurtoughSMStephen Murtough
- Daniele PanconesiDPDaniele Panconesi
- Chen LuCLChen Lu
- Rosemary AbidophRARosemary Abidoph
- Marius CoticMCMarius Cotic
- Daisy MillsDMDaisy Mills
- Alvin Richards-BelleARAlvin Richards-Belle
- Maria Richards-BrownMaria Richards-Brown
- Noushin Saadullah KhaniNKNoushin Saadullah Khani
- Lauren VarneyLVLauren Varney
- Jennifer F LindenJLJennifer F Linden
- Elvira BramonEBElvira Bramon
Open Access
- 24 September 2024
- journal article
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 546
Abstract
Background Hearing loss is a risk factor for developing auditory hallucinations and other psychosis symptoms. To date, very little research has investigated hearing loss in individuals with a high genetic risk of developing schizophrenia and other types of psychosis. 13 copy number variant (CNV) loci are robustly associated with an increased risk of schizophrenia. Of these, microdeletions at 22q11.2 often lead to some hearing loss, and mouse models of this CNV display impaired auditory functioning. We hypothesise that hearing impairment is an understudied mechanism that contributes to the formation of psychosis symptoms in individuals at high genetic risk. This scoping review will explore whether the 13 schizophrenia-associated CNVs are related to hearing problems, including peripheral hearing loss and other auditory problems, in humans and related mouse models. Methods Our scoping review will follow guidelines provided by the Joanna Briggs Institute and the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews. A systematic search will be completed using PubMed (MEDLINE), Embase, PsychINFO, and Cochrane Library databases, as well as other sources to identify relevant grey literature. Search terms will include all commonly used synonyms for hearing loss and problems with auditory perception, and both human and mouse studies that describe relevant CNVs will be included. Search lists will be screened by two authors independently, according to eligibility criteria, and data will be extracted and summarised using a narrative approach, and meta-analysis methods will be used if possible. Conclusions To our knowledge, this will be the first scoping review to explore auditory functioning across all CNVs that confer high schizophrenia risk. Looking ahead, if hearing problems are a clinical feature in these groups (including humans and related mouse models), they may serve as useful genetic models for future mechanistic studies.Keywords
Funding Information
- Wellcome Trust (218497)
- Wellcome Trust (084779)
This publication has 19 references indexed in Scilit:
- Schizophrenia: from neurochemistry to circuits, symptoms and treatmentsNature Reviews Neurology, 2023
- Mapping genomic loci implicates genes and synaptic biology in schizophreniaNature, 2022
- Genetic copy number variants, cognition and psychosis: a meta-analysis and a family studyMolecular Psychiatry, 2020
- Auditory hallucinations in adults with hearing impairment: a large prevalence studyPsychological Medicine, 2018
- Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjectsNature Genetics, 2016
- Prevalence of hearing loss in children with 22q11.2 deletion syndromeInternational Journal of Pediatric Otorhinolaryngology, 2016
- Increased risk of psychosis in patients with hearing impairment: Review and meta-analysesNeuroscience & Biobehavioral Reviews, 2016
- What can we learn from the high rates of schizophrenia in people with 22q11.2 deletion syndrome?World Psychiatry, 2016
- 22q11.2 deletion syndromeNature Reviews Disease Primers, 2015
- Hearing loss; the neglected risk factor for psychosisSchizophrenia Research, 2014